Sarepta Therapeutics, Inc. SEC filings SRPT
Sarepta Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 31, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Apr 16, 2020 | — |
| CORRESP | Letter to the SEC | Apr 15, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2020 | — |
| D | Filing | Feb 28, 2020 | — |
| D | Filing | Nov 25, 2019 | — |
| CT ORDER | Filing | Nov 9, 2018 | — |
| CT ORDER | Filing | Sep 12, 2017 | — |
| CT ORDER | Filing | Jan 19, 2017 | — |
| CT ORDER | Filing | Oct 4, 2016 | — |
| EFFECT | Filing | May 5, 2015 | — |
| CORRESP | Letter to the SEC | May 4, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2015 | — |
| CORRESP | Letter to the SEC | Apr 28, 2015 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2015 | — |
| POSASR | Filing | Feb 26, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2014 | — |
| CORRESP | Letter to the SEC | Feb 13, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2014 | — |
| CORRESP | Letter to the SEC | Jan 6, 2014 | — |
| CORRESP | Letter to the SEC | Dec 20, 2013 | — |
| CORRESP | Letter to the SEC | Dec 13, 2013 | — |
| UPLOAD | Letter from the SEC | Nov 25, 2013 | — |
| CT ORDER | Filing | Jun 13, 2013 | — |
| POSASR | Filing | Jun 7, 2013 | — |
| 8-K12B | Filing | Jun 6, 2013 | May 31, 2013 |
| CT ORDER | Filing | Nov 16, 2012 | — |
| EFFECT | Filing | Aug 13, 2012 | — |
| CORRESP | Letter to the SEC | Aug 9, 2012 | — |
| CT ORDER | Filing | Apr 20, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2012 | — |
| CT ORDER | Filing | Feb 21, 2012 | — |
| CT ORDER | Filing | Sep 19, 2011 | — |
| CT ORDER | Filing | Aug 29, 2011 | — |
| CT ORDER | Filing | May 23, 2011 | — |
| CT ORDER | Filing | Apr 8, 2011 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SRPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 873303
- Former names
- Sarepta Therapeutics, Inc. (until Nov 5, 2026); AVI BIOPHARMA INC (until Jul 12, 2012); ANTIVIRALS INC (until May 12, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.